Clinical Trial Update: The Use of Fish Oil Supplementation in Treatment of Intrahepatic Cholestasis of Pregnancy [NA]

View source ↗

Summary

A clinical trial evaluating fish oil (omega-3 fatty acids) supplementation for intrahepatic cholestasis of pregnancy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrahepatic Cholestasis of Pregnancy

Drugs mentioned

• Fish oil supplementation (Omega-3 fatty acids)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Intrahepatic Cholestasis of Pregnancy | NA | Status: WITHDRAWN